secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-03-23T23:59:59+00:00
Accession:  0001193125-23-077886
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex awards stock options and raises base salaries for top executives
-------------------------------------------------------------------------

- CEO Maurice Zauderer receives option for 56,000 shares at 110% of FMV, vesting over 4 years, 5-year expiry.
- CSO Ernest Smith receives option for 40,000 shares; CFO Scott Royer receives option for 32,000 shares; vesting 4 years, 10-year expiry.
- Base salaries increased 5% effective April 1: CEO $426,930, CSO $302,380, CFO $275,334.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523077886/0001193125-23-077886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523077886/d274897d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-077886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer